lncRNA AGAP2-AS1 Facilitates Tumorigenesis and Ferroptosis Resistance through SLC7A11 by IGF2BP2 Pathway in Melanoma

Lifeng An, Jingwen Huang, Shihui Ge, Xin Zhang, Jing Wang

Open source

DOI
10.1155/2022/1972516
Published
2022-06-06
Container
Computational and Mathematical Methods in Medicine
Publisher
Wiley
Open access
unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1155/2022/1972516,
  title = {lncRNA AGAP2-AS1 Facilitates Tumorigenesis and Ferroptosis Resistance through SLC7A11 by IGF2BP2 Pathway in Melanoma},
  author = {Lifeng An and Jingwen Huang and Shihui Ge and Xin Zhang and Jing Wang},
  year = {2022},
  journal = {Computational and Mathematical Methods in Medicine},
  doi = {10.1155/2022/1972516},
  url = {https://doi.org/10.1155/2022/1972516}
}

RIS

TY  - JOUR
TI  - lncRNA AGAP2-AS1 Facilitates Tumorigenesis and Ferroptosis Resistance through SLC7A11 by IGF2BP2 Pathway in Melanoma
AU  - Lifeng An
AU  - Jingwen Huang
AU  - Shihui Ge
AU  - Xin Zhang
AU  - Jing Wang
PY  - 2022
JO  - Computational and Mathematical Methods in Medicine
DO  - 10.1155/2022/1972516
UR  - https://doi.org/10.1155/2022/1972516
ER  - 

APA

An, L., Huang, J., Ge, S., Zhang, X., & Wang, J. (2022). lncRNA AGAP2-AS1 Facilitates Tumorigenesis and Ferroptosis Resistance through SLC7A11 by IGF2BP2 Pathway in Melanoma. Computational and Mathematical Methods in Medicine. https://doi.org/10.1155/2022/1972516

Source records